Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Jun 23 424B3 Prospectus supplement
- 19 May 23 424B3 Prospectus supplement
- 12 May 23 424B3 Prospectus supplement
- 12 May 23 424B3 Prospectus supplement
- 28 Apr 23 424B4 Prospectus supplement with pricing info
- 28 Apr 23 POS EX Additional exhibits for listing
- 27 Apr 23 EFFECT Notice of effectiveness
- 21 Apr 23 S-1/A IPO registration (amended)
- 17 Apr 23 S-1/A IPO registration (amended)
- 4 Apr 23 S-1/A IPO registration (amended)
-
13 Feb 23 S-1/A IPO registration (amended)
- 27 Jan 23 S-1 IPO registration
ZVSA similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 8, 2022, in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-269442) and related Prospectus of ZyVersa Therapeutics, Inc. for the registration of shares of its common stock, pre-funded warrants and warrants.
/s/ Ernst & Young LLP
Miami, Florida
February 13, 2023